|Videos|August 23, 2020

What keeps ophthalmologists up at night?

Ophthalmologists share what keeps them up at night in the ophthalmic profession amid the pandemic.

Daniel Kiernan, MD, FACS; Justis Ehlers, MD; and Dilraj Grewal, MD, share what keeps them up at night in the ophthalmic profession amid the pandemic with Ophthalmology Times'® David Hutton.

Newsletter

Don’t miss out—get Modern Retina updates delivered straight to your inbox.

Subscribe

Related Content

Cynthia Toth, MD, of the Duke Department of Ophthalmology

Using OCT to predict neurodevelopmental risk in preterm infants: Cynthia Toth, MD

ByCytnthia Toth, MD,Lucia Gambuzza,Abigail Lewis, Content Intern

July 8th 2026

Charles Wykoff, MD, PhD | Modern Retina Video

Revakinagene taroretcel-lwey for MacTel: Charles Wykoff, MD, PhD, on a year of real-world experience

ByCharles C. Wykoff, MD, PhD,Lucia Gambuzza

July 2nd 2026

The Wills Retina Report: Regillo and Garg on managing geographic atrophy—who, when, and how

ByCarl D. Regillo, MD, FACS, FASRS,Sunir J. Garg, MD, FACS, FASRS

June 26th 2026

(Image credit: Modern Retina/Ophthalmology Times)

Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, PhD

ByDavid A. Eichenbaum, MD, FASRS,Jay S. Duker, MD ,Ramiro Ribeiro, MD, PhD

June 19th 2026

Mark Barakat, MD | Modern Retina CTS coverage

CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice

ByMark R. Barakat, MD,Lucia Gambuzza

June 15th 2026

Latest CME

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

MacTel Decoded: Rethinking Conventional Approaches With Novel Neuroprotective Strategies

Charles C. Wykoff MD, PhD; Diana V. Do, MD; Dante Pieramici, MD, FASRS; Jed H. Assam, MD, MS

Video

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

What keeps ophthalmologists up at night?

Related Content

Using OCT to predict neurodevelopmental risk in preterm infants: Cynthia Toth, MD

Revakinagene taroretcel-lwey for MacTel: Charles Wykoff, MD, PhD, on a year of real-world experience

The Wills Retina Report: Regillo and Garg on managing geographic atrophy—who, when, and how

Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, PhD

CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

MacTel Decoded: Rethinking Conventional Approaches With Novel Neuroprotective Strategies

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Treatment Optimization in the Evolving Anti-VEGF Era

Trending on Eye Care Network - Ophthalmology Times

FDA requires NAION warning across the GLP-1 receptor agonist class

Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical cases

Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia

The interplay between cardiac disease and the eye

OT Roundup: GLP-1 NAION warning, LEMS clues, Eyedaptic Eva, AFib